Effects of carvedilol on mortality and inflammatory responses to severe hemorrhagic shock in rats

Shock

Volumn 32, Issue 3, 2009, Pages 272-275

  Taniguchi, Takumi ^a   Kurita, Akihide ^a   Yamamoto, Ken ^a   Inaba, Hideo ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

Blocker; Carvedilol; Cytokine; Hemorrhagic shock

Indexed keywords

CARVEDILOL; CYTOKINE; INTERLEUKIN 6; LACTIC ACID; PENTOBARBITAL; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL GAS; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; HEART ARREST; HEMODYNAMICS; HEMORRHAGIC SHOCK; INFLAMMATION; MALE; NONHUMAN; RAT; SURVIVAL RATE;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; CARBAZOLES; CARBON DIOXIDE; HEMODYNAMICS; MALE; OXYGEN; PROPANOLAMINES; RATS; RATS, SPRAGUE-DAWLEY; SHOCK, HEMORRHAGIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 69549135350     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/SHK.0b013e3181a24cb3     Document Type: Article

References (13)

1. Packer M, Coats AJ, Fowler MB, Katus HA, Krum H, Mohacsi P, Rouleau JL, Tendera M, Castaigne A, Roecker EB, et al.: Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 344:1651-1658, 2001. (Pubitemid 32479962)
2. Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, Shusterman NH: The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. N Engl J Med 334:1349-1355, 1996.
3. Noguchi N, Nishino K, Niki E: Antioxidant action of the antihypertensive drug, carvedilol, against lipid peroxidation. Biochem Pharmacol 59:1069-1076, 2000.
4. Cleland JG, Charlesworth A, Lubsen J, Swedberg K, Remme WJ, Erhardt L, Di Lenarda A, Komajda M, Metra M, Torp-Pedersen C, et al.: A comparison of the effects of carvedilol and metoprolol on well-being, morbidity, and mortality (the "patient journey") in patients with heart failure: a report from the Carvedilol or Metoprolol European Trial (COMET). J Am Coll Cardiol 47:1603-1611, 2006.
5. Remme WJ, Torp-Pedersen C, Cleland JG, Poole-Wilson PA, Metra M, Komajda M, Swedberg K, Di Lenarda A, Spark P, Scherhag A, et al.: Carvedilol protects better against vascular events than metoprolol in heart failure: results from COMET. J Am Coll Cardiol 49:963-971, 2007. (Pubitemid 46335773)
6. Fonarow GC, Lukas MA, Robertson M, Colucci WS, Dargie HJ: Effects of carvedilol early after myocardial infarction: analysis of the first 30 days in Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction (CAPRICORN). Am Heart J 154:637-644, 2007. (Pubitemid 47429577)
7. Mangano DT, Layug EI, Wallace A, Tateo I: Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery: multicenter study of perioperative ischemia research group. N Engl J Med 335:1713-1720, 1996.
8. Poldermans D, Boersma E, Bax JJ, Thomson IR, van de Ven LL, Blankensteijn JD, Baars HF, Yo TI, Trocino G, Vigna C, et al.: The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. N Engl J Med 341:1789-1794, 1999.
9. Mizuochi Y, Okajima K, Harada N, Molor-Erdene P, Uchiba M, Komura H, Tsuda T, Katsuya H: Carvedilol, a nonselective beta-blocker, suppresses the production of tumor necrosis factor and tissue factor by inhibiting early growth response factor-1 expression in human monocytes in vitro. Transl Res 149:223-230, 2007. (Pubitemid 46442011)
10. Suzuki T, Morisaki H, Serita R, Yamamoto M, Kotake Y, Ishizaka A, Takeda J: Infusion of the beta-adrenergic blocker esmolol attenuates myocardial dysfunction in septic rats. Crit Care Med 33:2294-2301, 2005. (Pubitemid 41437484)
11. Schmitz D, Wilsenack K, Lendemanns S, Schedlowski M, Oberbeck R: beta-Adrenergic blockade during systemic inflammation: impact on cellular immune functions and survival in a murine model of sepsis. Resuscitation 72:286-294, 2007. (Pubitemid 46073346)
12. Taniguchi T, Yamamoto K, Ohmoto N, Ohta K, Kobayashi T: Effects of propofol on hemodynamic and inflammatory responses to endotoxemia in rats. Crit Care Med 28:1101-1106, 2000. (Pubitemid 30262086)
13. Taniguchi T, Kanakura H, Yamamoto K: Effects of posttreatment with propofol on mortality and cytokine responses to endotoxin-induced shock in rats. Crit Care Med 30:904-907, 2002. (Pubitemid 34297816)